Compounds > 4-butyrolactone
Page last updated: 2024-08-18

4-butyrolactone and parthenolide

4-butyrolactone has been researched along with parthenolide in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Bosisio, E; D'Ambrosio, M; Dell'Agli, M; Galli, GV1
Gagare, PD; Helppi, MA; Nair, HN; Nicponski, DR; Ramachandran, PV; Schmidt, CM; Yip-Schneider, MT1
An, T; Cai, B; Chen, L; Duan, A; Ju, X; Kong, L; Li, X; Li, Y; Yang, Q1
Contreras, JI; Karpf, AR; Kizhake, S; Kour, S; Natarajan, A; Rana, S; Robb, CM; Sonawane, YA; Zahid, M1

Other Studies

4 other study(ies) available for 4-butyrolactone and parthenolide

ArticleYear
Inhibition of NF-kB and metalloproteinase-9 expression and secretion by parthenolide derivatives.
    Bioorganic & medicinal chemistry letters, 2009, Apr-01, Volume: 19, Issue:7

    Topics: 4-Butyrolactone; Cell Line; Cyclobutanes; Down-Regulation; Humans; Inhibitory Concentration 50; Matrix Metalloproteinase 9; NF-kappa B; Sesquiterpenes; Transcription, Genetic

2009
Synthetic α-(aminomethyl)-γ-butyrolactones and their anti-pancreatic cancer activities.
    Bioorganic & medicinal chemistry letters, 2013, Dec-15, Volume: 23, Issue:24

    Topics: 4-Butyrolactone; Amination; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Humans; Pancreatic Neoplasms; Sesquiterpenes; Stereoisomerism; Structure-Activity Relationship

2013
Parthenolide inhibits ubiquitin-specific peptidase 7 (USP7), Wnt signaling, and colorectal cancer cell growth.
    The Journal of biological chemistry, 2020, 03-13, Volume: 295, Issue:11

    Topics: 4-Butyrolactone; Apoptosis; beta Catenin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Down-Regulation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Proteolysis; Sesquiterpenes; Ubiquitin-Specific Peptidase 7; Ubiquitination; Wnt Signaling Pathway

2020
Symbiotic prodrugs (SymProDs) dual targeting of NFkappaB and CDK.
    Chemical biology & drug design, 2020, Volume: 96, Issue:2

    Topics: 4-Butyrolactone; Amines; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinases; Drug Screening Assays, Antitumor; Female; Humans; Molecular Targeted Therapy; NF-kappa B; Ovarian Neoplasms; Piperazines; Piperidines; Prodrugs; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Sesquiterpenes; Signal Transduction; Structure-Activity Relationship

2020